Onaiza Cadoret-Manier

Onaiza Cadoret-Manier

DirectoratIonis Pharmaceuticals· In proxies 2021–2025

Pay in FY2023+18% from the year before · Ionis Pharmaceuticals stock +33.9% the same year

Onaiza Cadoret-Manier was paid $2.8M in FY2023 (Dec), up 18%. Ionis Pharmaceuticals stock rose 33.9% that year.

Pay$100 in the stock at the end of FY20 → $89
Pay is from the Summary Compensation Table of each Ionis Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ArdelyxPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Ionis PharmaceuticalsPublic company · 5 yr
    • Executive Vice President, Chief Global Product Strategy and Operations Officer2021 – Present · 5 yrStock in role -25%
  3. Ventyx BiosciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?